about
Endometriosis: a disease that remains enigmaticAromatase inhibitors for uterine fibroidsAromatase inhibitors for uterine fibroidsHormone therapy for endometriosis and surgical menopauseProceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsUse of aromatase inhibitors in practice of gynecologyAromatase inhibitors for the treatment of endometriosisImplications of immune dysfunction on endometriosis associated infertilityAromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons.CYP19 gene variant confers susceptibility to endometriosis-associated infertility in Chinese women.Aromatase inhibitors in post-menopausal endometriosis.Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis.5-Year data analysis of patients following abdominal wall endometrioma surgery.Do symptomatic endometriosis and uterine fibroids appear together?Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.Aromatase inhibition for refractory endometriosis-related chronic pelvic pain.Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for TherapySmall primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model.Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).Genome-wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosisEpidemiology of Uterine Fibroids: From Menarche to Menopause.Emerging drugs in endometriosis.Estrogen receptors and human disease: an update.Progestins activate the AKT pathway in leiomyoma cells and promote survival.Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosisAltered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biologyThe peritoneum--an important factor for pathogenesis and pain generation in endometriosis.Uterine fibroids: clinical manifestations and contemporary management.Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease.Adenomyosis: what is new?Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.Future of endometriosis research.Reduced aromatase activity in granulosa cells of women with endometriosis undergoing assisted reproduction techniques.Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.Pollakisuria in a dwarf goat due to pathologic enlargement of the uterus.Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.The Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma.Lipopolysaccharide promotes the development of murine endometriosis-like lesions via the nuclear factor-kappa B pathway.Neuroimmunomodulatory alterations in non-lesional peritoneum close to peritoneal endometriosis.
P2860
Q21285103-F2B27E8A-889D-4C38-8972-E86C50C8CB47Q24202922-E4256ABD-7CAF-46A4-9190-6E1F29BF6718Q24234688-040C00D0-550F-4854-8E1E-9A21B15D01CCQ24240923-9A82B66B-9BF2-43E7-B518-8927BA3E9108Q24567733-0CD0A2A2-1B00-499F-9C23-6AE4F652DFEFQ27001218-B20719C6-C08B-4B33-99B5-B5B3185CCD10Q27010275-A34147E8-DD3D-40DB-BC16-7A440BEE82D5Q28066145-A5760C3F-C2F9-4E43-959A-684CA2178B71Q30543147-0EA8E5D1-21A9-4546-9DEB-2396D2D27AF5Q33844858-30C9845B-1BF8-424A-80E6-289B9E83847FQ34194386-1AFEDDA1-5478-41E5-9742-9BA31A12272CQ34622161-5823BA12-10A7-4001-9273-EA2F0B71B8C6Q34676984-FEC1F1C4-162F-4F9C-BC09-3B3D004EF831Q35104500-06C6B094-9EA7-4ADF-B9FC-10E498D95324Q35587188-96035E64-0B19-4FFA-841E-9712BB38F532Q35838301-B014991E-159E-4452-A4E0-70F5021B7F71Q35855640-46A0596E-E9BB-48BA-9761-C0FCBAE35455Q35880398-8A9D8538-B368-454B-A939-46B163D29C45Q36114008-5F69DEF0-1149-4768-941D-A3DA33D7A069Q36431640-F8F7542B-1995-40FF-B7A4-F04DD1E4FD87Q36498607-8E8D390C-F5C3-43A4-A958-15C0ACC69B4BQ36522644-67D31216-7E42-4931-B3AD-1986F00F9DF9Q36580603-80807B78-71DB-430D-AB29-29835281BEBDQ36661810-5FD5BB86-09D5-4723-9018-7B664676833FQ37198021-F6435299-C773-43F2-8798-B25977C9B8DDQ37248484-F97E4C21-CE45-4417-B712-A99BFE2BCE5AQ37381777-044BB47E-E75C-4683-AF4D-A04C53763BE2Q38192902-B057DC66-F1B8-46B7-87AA-5E8DBBD79354Q38211241-0A9D587A-3EF8-4E8B-B3B1-0008F34151ACQ38446659-1338D99D-502E-4B4F-9F69-663D8120DAE4Q38575388-4AA3B327-5E70-4626-B101-AD7DBD14FF9AQ38792320-22A68194-F43E-4158-83DA-B05ADBDC3071Q40179154-40CB40A6-3574-4352-ADDF-A553E418F0E5Q42502108-4DFD16DC-7E1F-4F09-BB92-BCA22665A683Q44819882-F8A3ABBE-DAC4-49CB-A519-FF7A63AAF519Q46923905-64FBA994-28A0-4868-8A6E-8B04EBD68FE5Q46938210-552B3F4B-EE9F-4606-853A-0ADB4EA9FBFAQ47561375-CF64EC0B-786F-458C-9206-C14DF57799FEQ50922785-2BEC8BCD-CB80-4CC5-BEC3-65F7B1073C7AQ52886072-361828C7-31F1-48F6-9DA4-464E16B632C8
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aromatase in endometriosis and uterine leiomyomata.
@ast
Aromatase in endometriosis and uterine leiomyomata.
@en
Aromatase in endometriosis and uterine leiomyomata.
@nl
type
label
Aromatase in endometriosis and uterine leiomyomata.
@ast
Aromatase in endometriosis and uterine leiomyomata.
@en
Aromatase in endometriosis and uterine leiomyomata.
@nl
prefLabel
Aromatase in endometriosis and uterine leiomyomata.
@ast
Aromatase in endometriosis and uterine leiomyomata.
@en
Aromatase in endometriosis and uterine leiomyomata.
@nl
P2093
P1476
Aromatase in endometriosis and uterine leiomyomata.
@en
P2093
Bilgin Gurates
Gonca Imir
Hiroki Utsunomiya
Mitsutoshi Tamura
Serdar E Bulun
Steven Thung
Zhihong Lin
P356
10.1016/J.JSBMB.2005.04.012
P577
2005-05-01T00:00:00Z